Genetic risk for coronary artery disease in individuals with or without type 2 diabetes (Q45874250)

17 December 2017

title

Genetic risk for coronary artery disease in individuals with or without type 2 diabetes (English)

1 reference

17 December 2017

1 reference

coronary artery disease

1 reference

Yoshiji Yamada

1

1 reference

17 December 2017

Sahoko Ichihara

2

1 reference

17 December 2017

Hideo Izawa

3

1 reference

17 December 2017

Masashi Tanaka

4

1 reference

17 December 2017

Mitsuhiro Yokota

5

1 reference

17 December 2017

publication date

1 April 2004

1 reference

17 December 2017

Molecular Genetics and Metabolism

published in

1 reference

17 December 2017

volume

81

1 reference

17 December 2017

issue

4

1 reference

17 December 2017

page(s)

282-290

1 reference

17 December 2017

Banting lecture 1988. Role of insulin resistance in human disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

UK prospective diabetes study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Paraoxonase 192 Gln/Arg gene polymorphism, coronary artery disease, and myocardial infarction in type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Common DNA polymorphisms at the lipoprotein lipase gene. Association with severity of coronary artery disease and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Report of the Committee on the classification and diagnostic criteria of diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Prediction of the risk of myocardial infarction from polymorphisms in candidate genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

The pathogenesis of atherosclerosis: a perspective for the 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Individual gap junction plaques contain multiple connexins in arterial endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Multiple connexin expression in regenerating arterial endothelial gap junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Molecular cloning and functional expression of human connexin37, an endothelial cell gap junction protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Connexin37 gene polymorphism and coronary artery disease in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Association between Ala54Thr substitution of the fatty acid-binding protein 2 gene with insulin resistance and intra-abdominal fat thickness in Japanese men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

The T 54 allele of the intestinal fatty acid-binding protein 2 is associated with a parental history of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Variants of the fatty acid-binding protein 2 gene are not associated with coronary heart disease in nondiabetic subjects and in patients with NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Gene polymorphisms in the TNF locus and the risk of myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Polymorphisms in the TNF-alpha and TNF-receptor genes in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Role of tumor necrosis factor-alpha gene locus in obesity and obesity-associated hypertension in French Canadians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

A common functional polymorphism (C-->A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Apolipoprotein E: cholesterol transport protein with expanding role in cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations--the ECTIM Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

Blood pressure, coronary artery disease, and glycaemic control in type 2 diabetes mellitus: relation to apolipoprotein-CIII gene polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2004.01.014

10.1016/J.YMGME.2004.01.014

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017